Johanna Winant, an assistant professor in the West Virginia University Department of English, has accepted a distinguished fellowship at the Notre Dame Institute for Advanced Study at the University of Notre Dame to work on her book project.
Two WVU researchers have found that babies exposed to Suboxone in utero fared as well as, or better than babies exposed to more conventional addiction treatments, such as treatment with methadone or Subutex.
As female involvement in West Virginia’s agriculture industry continues to grow, West Virginia University Extension Service’s Women in Agriculture team recognizes that the responsibility falls on their programming to help fulfill the needs of our state’s women farmers, innovators and entrepreneurs.
Director of Athletics Shane Lyons unveiled today (Aug. 2) the $100 million fundraising campaign for WVU Athletics' capital projects.
Andrew Dacks, assistant professor of neuroscience in the Department of Biology , received a $1.3 million grant from the National Institutes of Health to conduct research at West Virginia University on the effects of serotonin in fruit flies. Dacks and his team of researchers will study how serotonin affects different cells in the olfactory system of fruit flies and how those systems could apply to other systems as well.
Tune in Sunday to see West Virginia University President Gordon Gee, bowtie and all, hammering nails and sawing wood as the Barnwood Builders episode, taped earlier this year at WVU Jackson’s Mill, airs on the DIY network Sunday (Aug. 5) at 9 p.m.
For the fourth straight year, the West Virginia University Foundation’s annual giving program received a record number of donations. Between July 1, 2017 and June 30, 2018, donors gave $22.3 million to the University Fund surpassing the previous record high of $21.6 million in FY ’17.
What do one in five breast cancers have in common? Large amounts of a protein called HER2 (or human epidermal growth factor receptor 2). “Every healthy cell produces a normal amount of HER2, but HER2 is produced 10 to 20 times more in a cancer cell,” said Yehenew Agazie, an associate professor of biochemistry at the West Virginia University School of Medicine.
West Virginia University (WVU) has been selected as the first site for an innovative clinical trial to treat Alzheimer’s disease. Ali Rezai, M.D., director of the WVU Rockefeller Neuroscience Institute, will lead the initiative in collaboration with INSIGHTEC, an Israel-based medical technology company who received approval by the U.S. Food and Drug Administration (FDA) to begin the clinical trial using focused ultrasound to treat Alzheimer’s.
An award-winning teacher and researcher who has served in several leadership roles at West Virginia University will guide the College of Education and Human Services as interim dean, an appointment that will likely encompass the next academic year.